TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
COCH

Envoy Medical Inc.

Healthcare · Medical Devices

6.60$ +2.0% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Envoy Medical Inc. (COCH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.8% of the shares are freely tradable; institutional investors hold 22.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 22.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 40.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 55.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 8Mio.

Largest Shareholders

Institutions

Institutions COCH
Name Stake (%) Shares Change (%) Date
Nantahala Capital Management, LLC 19.77 15,300,000 +100.0 06/30/2026
Bleichroeder LP 8.08 6,250,000 +0.0 06/30/2026
Vanguard Capital Management, LLC 1.14 880,214 -0.2 06/30/2026
Geode Capital Management, LLC 0.70 541,729 +3.8 06/30/2026
The Colony Group LLC 0.55 425,310 +100.0 06/30/2026
Vanguard Fiduciary Trust Co 0.38 296,679 +0.7 06/30/2026
UBS Group AG 0.25 190,838 +170.8 06/30/2026
Arcus Capital Partners LLC 0.24 187,573 +0.0 06/30/2026

Funds

Funds COCH
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 0.35 273,565 +0.0 09/30/2026
Fidelity Extended Market Index 0.32 251,247 -0.5 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?